Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315709544> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4315709544 endingPage "e455" @default.
- W4315709544 startingPage "e455" @default.
- W4315709544 abstract "Objective: Abnormalities of renin-angiotensin system (RAS) and renal function have been reported in young spontaneously hypertensive rats (SHR) and blood pressure (BP) can be permanently reset to lower levels after brief early treatment with RAS inhibitors. We sought to determine whether renal renin was affected long-term by early RAS blockade. Design: Male SHR were treated via minipump from 10–14 weeks of age with vehicle (Veh, n = 12) or losartan (Los, n = 14, 7.5 mg/kg/d). Four Veh and six Los SHR were culled at 14-weeks and the remaining animals at 20-weeks. To control for effects of low BP another group received hydralazine (HZ, n = 6, 1 mg/kg/d) from 10–20 weeks. Methods: At 14- and 20-weeks systolic BP was measured, and kidneys collected. Three micrometer paraffin sections of renal cortices were counterstained with hematoxylin for renin immunolabelling, assessed for each animal as the percentage of labelling in 200 glomeruli which displayed the afferent arteriole entering the glomerulus. Results: At 14-weeks the systolic BP (mean ± SEM) was significantly (P < 0.001 by ANOVA) lower in both the Los (145 ± 7 mmHg) and HZ (153 ± 7 mmHg) SHR compared with Veh (206 ± 6 mmHg). At 20-weeks, the same pattern persisted (Los: 187 ± 6 mmHg; HZ: (155 ± 4 mmHg; Veh: 220 ± 6 mmHg) (P < 0.001 by ANOVA). Renal renin immunolabelling increased dramatically during treatment at 14-weeks (44.8 ± 1.1%) compared with Veh (10.5 ± 1.7%) (P < 0.0001 by ANOVA). However, at 20-weeks renal renin was significantly lower in Los (7.7 ± 0.9%) (P < 0.05 by ANOVA) compared with Veh (11.9 ± 1.2%), while renal renin was significantly higher in HZ kidneys (18.0 ± 1.0%) than both Los and Veh kidneys (P < 0.01 by ANOVA). Conclusions: The persistently low BP in SHR following brief early treatment with losartan is associated with reduced renal renin. Normally one would expect activation of the renal RAS with lower BP, as observed with the hydralazine-treated SHR. These results suggest that long-term reduction in renal renin following brief early RAS blockade in SHR might cause the persistently reduced BP seen in these animals." @default.
- W4315709544 created "2023-01-12" @default.
- W4315709544 creator A5000873384 @default.
- W4315709544 creator A5018173977 @default.
- W4315709544 creator A5044768037 @default.
- W4315709544 creator A5054306612 @default.
- W4315709544 creator A5080342367 @default.
- W4315709544 creator A5082795470 @default.
- W4315709544 creator A5085756110 @default.
- W4315709544 date "2023-01-01" @default.
- W4315709544 modified "2023-10-03" @default.
- W4315709544 title "PS-B12-7: PERSISTENT REDUCTION IN RENAL RENIN FOLLOWING EARLY TREATMENT OF SPONTANEOUSLY HYPERTENSIVE RATS WITH LOSARTAN" @default.
- W4315709544 doi "https://doi.org/10.1097/01.hjh.0000917516.55941.31" @default.
- W4315709544 hasPublicationYear "2023" @default.
- W4315709544 type Work @default.
- W4315709544 citedByCount "0" @default.
- W4315709544 crossrefType "journal-article" @default.
- W4315709544 hasAuthorship W4315709544A5000873384 @default.
- W4315709544 hasAuthorship W4315709544A5018173977 @default.
- W4315709544 hasAuthorship W4315709544A5044768037 @default.
- W4315709544 hasAuthorship W4315709544A5054306612 @default.
- W4315709544 hasAuthorship W4315709544A5080342367 @default.
- W4315709544 hasAuthorship W4315709544A5082795470 @default.
- W4315709544 hasAuthorship W4315709544A5085756110 @default.
- W4315709544 hasBestOaLocation W43157095441 @default.
- W4315709544 hasConcept C126322002 @default.
- W4315709544 hasConcept C134018914 @default.
- W4315709544 hasConcept C159641895 @default.
- W4315709544 hasConcept C198710026 @default.
- W4315709544 hasConcept C2780091579 @default.
- W4315709544 hasConcept C2780288358 @default.
- W4315709544 hasConcept C2780521442 @default.
- W4315709544 hasConcept C2780636983 @default.
- W4315709544 hasConcept C71924100 @default.
- W4315709544 hasConcept C84393581 @default.
- W4315709544 hasConcept C99476002 @default.
- W4315709544 hasConceptScore W4315709544C126322002 @default.
- W4315709544 hasConceptScore W4315709544C134018914 @default.
- W4315709544 hasConceptScore W4315709544C159641895 @default.
- W4315709544 hasConceptScore W4315709544C198710026 @default.
- W4315709544 hasConceptScore W4315709544C2780091579 @default.
- W4315709544 hasConceptScore W4315709544C2780288358 @default.
- W4315709544 hasConceptScore W4315709544C2780521442 @default.
- W4315709544 hasConceptScore W4315709544C2780636983 @default.
- W4315709544 hasConceptScore W4315709544C71924100 @default.
- W4315709544 hasConceptScore W4315709544C84393581 @default.
- W4315709544 hasConceptScore W4315709544C99476002 @default.
- W4315709544 hasIssue "Suppl 1" @default.
- W4315709544 hasLocation W43157095441 @default.
- W4315709544 hasLocation W43157095442 @default.
- W4315709544 hasOpenAccess W4315709544 @default.
- W4315709544 hasPrimaryLocation W43157095441 @default.
- W4315709544 hasRelatedWork W1560543947 @default.
- W4315709544 hasRelatedWork W1969123217 @default.
- W4315709544 hasRelatedWork W2038571733 @default.
- W4315709544 hasRelatedWork W2044747643 @default.
- W4315709544 hasRelatedWork W2047608102 @default.
- W4315709544 hasRelatedWork W2055062631 @default.
- W4315709544 hasRelatedWork W2077998387 @default.
- W4315709544 hasRelatedWork W2098037832 @default.
- W4315709544 hasRelatedWork W2126797993 @default.
- W4315709544 hasRelatedWork W2127085070 @default.
- W4315709544 hasVolume "41" @default.
- W4315709544 isParatext "false" @default.
- W4315709544 isRetracted "false" @default.
- W4315709544 workType "article" @default.